QuidelOrtho Corporation/QDEL

$40.40

3.37%
-
1D1W1MYTD1YMAX

About QuidelOrtho Corporation

QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.

Ticker

QDEL

Sector

Healthcare

Trading on

NASDAQ

Industry

Healthcare Facilities

CEO

Michael Iskra

Employees

7,100

Headquarters

San diego, United States

QDEL Metrics

BasicAdvanced
$2.62B
Market cap
-
P/E ratio
-$0.15
EPS
0.19
Beta
-
Dividend rate
$2.62B
0.19175
$95.02
$37.78
1.11M
1.572
0.879
45.442
48.235
20.452
1.71%
-0.12%
-0.2%
-0.13%
0.873
0.521
36.901
-8.21%
-101.45%
21.74%

What the Analysts think about QDEL

Analyst Ratings

Majority rating from 7 analysts.
Hold

Price Targets

Average projection from 5 analysts.
46.04% upside
High $81.00
Low $40.00
$40.40
Current price
$59.00
Average price target

QDEL Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.94% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$742.6M
-0.19%
Net income
$7M
-155.12%
Profit margin
0.94%
-155.29%

QDEL Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 42.87%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$1.80
$0.26
$0.90
$1.17
-
Expected
$1.49
$0.28
$0.60
$2.05
$0.54
Surprise
20.6%
-6.98%
50.75%
-42.87%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for QuidelOrtho Corporation stock?

QuidelOrtho Corporation (QDEL) has a market cap of $2.62B as of April 24, 2024.

What is the P/E ratio for QuidelOrtho Corporation stock?

The price to earnings (P/E) ratio for QuidelOrtho Corporation (QDEL) stock is 0 as of April 24, 2024.

Does QuidelOrtho Corporation stock pay dividends?

No, QuidelOrtho Corporation (QDEL) stock does not pay dividends to its shareholders as of April 24, 2024.

When is the next QuidelOrtho Corporation dividend payment date?

QuidelOrtho Corporation (QDEL) stock does not pay dividends to its shareholders.

What is the beta indicator for QuidelOrtho Corporation?

QuidelOrtho Corporation (QDEL) has a beta rating of 0.19. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the QuidelOrtho Corporation stock price target?

The target price for QuidelOrtho Corporation (QDEL) stock is $59, which is 46.04% above the current price of $40.4. This is an average based on projections from 5 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell QuidelOrtho Corporation stock

Buy or sell QuidelOrtho Corporation stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing